CD274 and triple-negative breast carcinoma: Several tumor-intrinsic mechanisms induce constitutive PD-L1 expression due to genetic alterations such as the genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 enriched in high-risk triple-negative breast cancer [62,63,64].